Free tool
Stocks near their 52-week high
We cover 24 companies trading within 5% of their own 52-week high. The median market value in the group is $10.52B. Across the group, the median move over the past trading day is +0.52%. 96% of the 23 with a 200-day average trade above it. Price change over the past year runs from +20.8% to +142.3% across the middle 80 percent of the group, with a median of +49.3%.
Other lists in this group
Table
24 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | $270.00 | +1.23% | +31.66% | +55.40% | Oct 13, 2026 |
| JNJ.DE | Johnson & Johnson | 234.20 EUR | −0.62% | +34.82% | +58.93% | Oct 13, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% | Oct 21, 2026 |
| TN8.DE | Thermo Fisher Scientific Inc. | 537.00 EUR | +5.63% | +6.86% | +29.67% | Oct 21, 2026 |
| ARGX | argenx SE | $1,047.10 | +20.05% | +24.66% | +47.90% | Oct 22, 2026 |
| DGX | Quest Diagnostics Incorporated | $245.00 | +3.84% | +42.24% | +38.12% | Oct 20, 2026 |
| INCY | Incyte Corporation | $128.12 | −1.39% | +26.33% | +51.01% | Oct 27, 2026 |
| THC | Tenet Healthcare Corporation | $274.19 | +4.40% | +37.47% | +50.70% | Oct 27, 2026 |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | 469.60 SEK | −0.76% | +42.13% | +61.26% | Oct 27, 2026 |
| EXEL | Exelixis, Inc. | $56.10 | −0.73% | +28.73% | +45.68% | Oct 27, 2026 |
| RVTY | Revvity, Inc. | $126.35 | +13.31% | +28.91% | +42.93% | Oct 26, 2026 |
| CHE | Chemed Corporation | $548.56 | +5.98% | +29.61% | +20.79% | Oct 27, 2026 |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% | Oct 21, 2026 |
| RCUS | Arcus Biosciences, Inc. | $30.76 | +13.72% | +32.07% | +191.29% | Oct 27, 2026 |
| BBZA.DE | BB Biotech AG | 33.40 EUR | 0.00% | +7.22% | +7.22% | Oct 23, 2026 |
| ATRC | AtriCure, Inc. | $48.17 | +21.18% | +22.66% | +29.14% | Oct 27, 2026 |
| NEO | NeoGenomics, Inc. | $17.37 | +29.63% | +47.70% | +145.34% | Oct 27, 2026 |
| VIMIAN.ST | Vimian Group AB (publ) | 35.35 SEK | +1.58% | +15.22% | +12.01% | Oct 22, 2026 |
| ANGO | AngioDynamics, Inc. | $15.69 | +9.41% | +23.74% | +56.74% | Oct 1, 2026 |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% | Oct 22, 2026 |
| TRMED.OL | Thor Medical ASA | 6.76 NOK | +51.91% | +34.93% | +135.13% | Aug 28, 2026 |
| XUP.DE | Genfit S.A. | 14.08 EUR | −1.81% | +164.41% | +166.82% | Sep 29, 2026 |
| BION.SW | BB Biotech AG | 56.70 CHF | +8.21% | +37.62% | +84.12% | Oct 23, 2026 |
| NOVN.SW | Novartis AG | 128.34 CHF | −1.08% | +21.88% | +30.24% | Oct 27, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.